Charles River Laboratories International Inc
Change company Symbol lookup
Select an option...
CRL Charles River Laboratories International Inc
BAC Bank of America Corp
CMSQF Computershare Ltd
UNH UnitedHealth Group Inc
RYAAY Ryanair Holdings PLC
FNGO MicroSectors? FANG+? Index 2X Leveraged ETN
VIVC Vivic Corp
LAD Lithia Motors Inc
SBUX Starbucks Corp
HYLN Hyliion Holdings Corp
Go

Health Care : Life Sciences Tools & Services | Mid Cap Growth
Company profile

Charles River Laboratories International, Inc. is an early-stage contract research company. The Company is engaged in laboratory animal medicine and science (research model technologies) and develop a portfolio of discovery and safety assessment services, both good laboratory practice (GLP) and non-GLP, which supports its clients from target identification through non-clinical development. The Company operates in three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Support (Manufacturing). The RMS segment includes Research Models and Research Model Services. The DSA segment includes Discovery Services and Safety Assessment. The Manufacturing segment includes Microbial Solutions, Avian, Biologics and Contract Manufacturing. The Company also provides a suite of products and services to support the Company's clients' manufacturing activities.

Closing Price
$227.70
Day's Change
-1.24 (-0.54%)
Bid
--
Ask
--
B/A Size
--
Day's High
229.74
Day's Low
220.87
Volume
(Heavy Day)
Volume:
488,724

10-day average volume:
378,363
488,724

Display:

Providers:

UpdateCancel
6 providers
October 29, 2020
Charles River Laboratories Announces Third-Quarter 2020 Results

--- Third-Quarter GAAP Earnings per Share of $2.03 and Non-GAAP Earnings per Share of $2.33 - --- Increases 2020 Guidance - Charles River Laboratories International, Inc. (NYSE: CRL) today reported its results for the third quarter of 2020. For the...(BusinessWire)

October 16, 2020
Charles River Laboratories Adds George Llado to Board of Directors

Charles River Laboratories International, Inc. (NYSE: CRL) today announced the appointment of George Llado, Senior Vice President and Chief Information Officer of Alexion Pharmaceuticals, Inc., to its Board of Directors. Mr. Llado's extensive...(BusinessWire)

October 13, 2020
Charles River Laboratories Schedules Third-Quarter 2020 Earnings Release and Conference Call

Charles River Laboratories International, Inc. (NYSE: CRL) will release third-quarter 2020 financial results on Thursday, October 29th, before the market opens. A conference call has been scheduled to discuss this information on Thursday, October...(BusinessWire)

September 08, 2020
Charles River Laboratories to Present at September Investor Conferences

Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it will virtually present at three upcoming investor conferences, including: Wells Fargo 2020 Healthcare Conference on Wednesday, September 9th, at 8:40 a.m...(BusinessWire)

August 05, 2020
Charles River Laboratories Announces Second-Quarter 2020 Results

--- Second-Quarter GAAP Earnings per Share of $1.34 and Non-GAAP Earnings per Share of $1.58 - --- Increases 2020 Guidance - --- Announces Proposed Acquisition of Cellero in the High-Growth Cell Therapy Market - (BusinessWire)

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.